FH-1701

N/A

Report date: 2024/03/25 15:27:20

Base Information

Drug NameFH-1701
Drug Alias NameFH1701FH-1701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 modulatorsDual specificity mitogen-activated protein kinase kinase 2 modulators
TargetsDual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Therapy Area/IndicationsArteriovenous MalformationsNeurofibromatosis 1Glioblastoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsArteriovenous MalformationsNeurofibromatosis 1Glioblastoma +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A